by Comite Web | Oct 27, 2025 | Sin categorizar
|
|
|
|
|
Next Tuesday, November 4, 2025, from 09:00h to 16:00h, a very special event will be held at the Ramón y Cajal Hospital in Madrid: the 10th edition of the Carmen Delgado / Miguel Pérez-Mateo Grant for pancreatic cancer research. 10 years promoting research against pancreatic cancer.
We celebrate 10 years promoting research, sharing knowledge and generating hope.
It will be a day to recognize achievements, share learnings and look to the future together, but also for something equally important: to bring research closer to patients and their families.
We want patients to understand the research, to know first-hand the advances, the evolution of the funded projects and the lines of work that are leading the way, as well as the clinical trials currently available in Spain.
A meeting between researchers, physicians, patients, family and friends, with the same purpose: to continue moving forward united by hope.
You can participate in person at the Ramón y Cajal Hospital in Madrid or online from anywhere.
Reserve your place and join us in this meeting for hope:
 Tuesday, November 4, 2025  From 9:00 a.m. to 4:00 p.m.  Assembly Hall of the Ramón y Cajal Hospital in Madrid |
|
|
|
|
|
|
|
|
|
|
by Comite Web | Oct 24, 2025 | Sin categorizar
IV ALIPANC Solidarity Gala
Friday, November 21 at 8:00 PM
Élkar Restaurant, Torre Emperador Castellana P.º de la Castellana, 259D, 33rd Floor, 28046 Madrid
Donation: €180 per person
Join the fight against pancreatic cancer
The Pancreatic Cancer Research Alliance in Spain (ALIPANC) invites you to the 4th edition of its Solidarity Gala, a charitable event held in honor of World Pancreatic Cancer Day.
This dinner aims to:
- Raise awareness about ALIPANC’s mission
- Collect funds for research
- Strengthen the commitment of our benefactors
ALIPANC brings together over 160 researchers from Spain and Portugal, working across hospitals and research centers in multicenter, multidisciplinary studies to improve the diagnosis, treatment, and survival of pancreatic cancer patients.
How can you help?
- Attend the gala: Share a meaningful evening with researchers, patients, and representatives from the business and public sectors.
- Support through “fila cero”: Contribute even if you cannot attend in person.
- Spread the word: Help raise public awareness about this disease.
Registration
Registration form https://forms.gle/EDhZkmVo7axLodzRA
Payment Options
- Bank transfer
IBAN: ES31 0182 9769 5102 0055 3107
- Bizum (Donate to NGO):
Code 10456
Formal attire requested.
by Comite Web | Oct 22, 2025 | Sin categorizar
On October 5–7, 2025, the annual United European Gastroenterology (UEG) Week in Berlin hosted the inaugural Digestive Disease Mechanisms (DDM) Summit, organized by Francisco X. Real, Mathias Heikenwälder, and Maria Sibilia. The DDM Summit marked the first basic research–focused program within UEG Week, which has traditionally been recognized for its clinical orientation. This new initiative aims to bridge the gap between clinicians and scientists, fostering translational collaboration across the fields of gastroenterology, hepatology, and pancreatic research.
The ALIPANC consortium was represented in Berlin by Francisco X. Real, Núria Malats, Chengsi Wu, and Mikhail Chesnokov. Chengsi Wu delivered an oral presentation on how gut microbiome dynamics shape pancreatic health in the context of Nr5a2 gene haploinsufficiency, presenting new evidence that microbiome-targeted strategies could offer preventive opportunities for pancreatic disease. Mikhail Chesnokov presented a poster revealing a novel role of the transcription factor NR5A2 in the regulation of intestinal epithelial cell fate and colon homeostasis. In recognition of their contributions, both researchers received travel grants to attend the summit, and Chengsi Wu was appointed as chair of the “Immune Mechanisms in Gastrointestinal Diseases” session.
The DDM Summit brought together leading experts in pancreatic disease research, including Grainne O’Kane, Dieter Saur, Laura Machesky, Andreas Trumpp, and Tuomas Tammela. Other Spanish scientists, including Eduard Batlle (IRB Barcelona), Nabil Djouder (CNIO), and Guadalupe Sabio (CNIO) delivered invited talks on colorectal and liver cancer.
The event fostered a productive exchange between clinicians and basic researchers, highlighting the growing integration of scientific discovery and medical practice within the UEG community.
Through its active participation, ALIPANC reaffirmed its commitment to supporting early-career scientists and promoting excellence in basic and translational research on the mechanisms underlying pancreatic disease. Following its successful debut, the DDM Summit is expected to become a regular feature of future UEG Week meetings.
by Comite Web | Oct 12, 2025 | Sin categorizar
The application period for the ALIPANC 2025 Elections is now open, on the occasion of the renewal of the ALIPANC Directive Board.
Below, we attach the related documentation:
📑 Application_form_ALIPANC2025
📓 Election_rules_ALIPANC2025
by Comite Web | Oct 9, 2025 | Sin categorizar
We share the schedule of upcoming sessions included in our monthly meetings, as well as the scientific activities planned for the coming months:
🔹 2025
🗓️ November 4, 2025
Title: Targeting the KRAS signaling network in pancreatic cancer
Speaker: Vicky Liaki (Barbacid Lab, CNIO, Madrid)
🗓️ December 2, 2025
Title: Development of Neoantigen-based Vaccines in Pancreatic Cancer
Speaker: Núria de la Iglesia (Irsicaixa, Badalona)
🔹 2026
🗓️ January 13, 2026
Title: PREVENPANC. Spanish Multicenter Study for the Prevention of Pancreatic Cancer.
Speaker: Leticia Moreira (Hospital Clínic, Barcelona)
🗓️ February 3, 2026
Title: Variation in CFTR expression can contribute to pancreatic cancer aggressiveness
Speaker: Raquel Ibáñez (VHIR – Xavier Molero Group)
🗓️ March 13, 2026
Event: Third ALIPANC Scientific Meeting. Face-to-face meeting in Madrid, which will give us the opportunity to share experiences, interact and foster new collaborations.
We will provide more details as the schedule is finalized, but we invite you to reserve this date in your calendars.
We encourage all members of the alliance to present their research at upcoming scientific meetings.
Your participation is key to strengthening the collaboration and further advancing our understanding of pancreatic cancer.
by Comite Web | Sep 19, 2025 | Sin categorizar
The second edition of the Botton-Champalimaud International Pancreatic Cancer Conference (BCIPCC) will take place from October 29th to November 1st, 2025, at the Botton-Champalimaud Pancreatic Cancer Centre in Lisbon.
Following the success of the inaugural 2024 conference, the event will again bring together global experts and healthcare professionals to discuss the latest advancements in pancreatic cancer diagnosis, treatment, and care. Topics will include innovative diagnostic techniques, emerging therapies, and cutting-edge research.
Have a look at the program!
More information and registration: https://www.bcipcc.org
